Interchange Capital Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$262K Buy
+4,732
New +$221K 0.08% 220
2025
Q2
Sell
-5,439
Closed -$302K 314
2025
Q1
$302K Sell
5,439
-109
-2% -$5.9K 0.08% 201
2024
Q4
$268K Sell
5,548
-539
-9% -$27.4K 0.1% 200
2024
Q3
$351K Sell
6,087
-45
-0.7% -$2.43K 0.12% 179
2024
Q2
$297K Buy
+6,132
New +$296K 0.11% 192
2023
Q2
Sell
-4,558
Closed -$249K 214
2023
Q1
$249K Buy
+4,558
New +$222K 0.14% 173
2021
Q1
Sell
-4,724
Closed -$229K 955
2020
Q4
$229K Buy
+4,724
New +$233K 0.12% 189

Other funds holding SNY

Interchange Capital Partners's SNY Position: Q1 2026 in Review

Interchange Capital Partners opened a new position in Sanofi (SNY) in Q1 2026: 4,732 shares worth $262K. The stake represents 0.08% of the portfolio and ranks #220 among its holdings. This is a return to the name: Interchange Capital Partners previously reported a position in SNY as recently as Q1 2025.

Interchange Capital Partners first reported a position in SNY in Q4 2020 and has held it in 7 quarters since. The position peaked at $351K in Q3 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Interchange Capital Partners held 4,732 shares of Sanofi worth $262K as of Q1 2026.
  • Sanofi was a new Interchange Capital Partners position in Q1 2026.
  • Sanofi made up 0.08% of Interchange Capital Partners's portfolio in Q1 2026, its #220 holding.
  • Interchange Capital Partners first reported a position in Sanofi in Q4 2020 and has held it in 7 quarters since.
  • Interchange Capital Partners's Sanofi position peaked at $351K in Q3 2024.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.